Buta M, Santrac N, Goran M, Jeftic N, Raketic J, Savkovic N
Diagnostics (Basel). 2025; 15(4).
PMID: 40002550
PMC: 11854757.
DOI: 10.3390/diagnostics15040399.
Garcia J, de Assumpcao L, Parisi M, Zantut-Wittmann D
Endocrine. 2024; 86(1):315-323.
PMID: 38748202
DOI: 10.1007/s12020-024-03870-9.
Dagdeviren Cakir A, Bucak F, Tarcin G, Turan H, Ozcan R, Evliyaoglu O
Sisli Etfal Hastan Tıp Bul. 2023; 57(2):224-231.
PMID: 37899815
PMC: 10600638.
DOI: 10.14744/SEMB.2023.09216.
de Sousa M, Nunes I, Christiano Y, Sisdelli L, Cerutti J
Rev Endocr Metab Disord. 2023; 25(1):35-51.
PMID: 37874477
DOI: 10.1007/s11154-023-09840-2.
Burgard C, Zacherl M, Todica A, Hornung J, Grawe F, Pekrul I
Front Oncol. 2023; 13:1237472.
PMID: 37849815
PMC: 10577432.
DOI: 10.3389/fonc.2023.1237472.
Tumor size is an independent negative prognostic factor for event free survival in children with differentiated thyroid cancer.
Parvathareddy S, Siraj A, Annaiyappanaidu P, Siraj N, Haqawi W, Al-Sobhi S
Front Endocrinol (Lausanne). 2022; 13:979054.
PMID: 36093088
PMC: 9452778.
DOI: 10.3389/fendo.2022.979054.
Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.
Howard S, Freeston S, Harrison B, Izatt L, Natu S, Newbold K
Endocr Relat Cancer. 2022; 29(11):G1-G33.
PMID: 35900783
PMC: 9513650.
DOI: 10.1530/ERC-22-0035.
Applicability of Adults 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines for Postoperative Risk Stratification and Postradioiodine Treatment Dynamic Risk Stratification in Pediatric Population.
Singh S, Mittal B, Sood A, Bhattacharya A, Kumar G, Shekhawat A
World J Nucl Med. 2022; 21(2):127-136.
PMID: 35865163
PMC: 9296250.
DOI: 10.1055/s-0042-1750334.
Aggressiveness of Differentiated Thyroid Carcinoma in Pediatric Patients Younger Than 16 years: A Propensity Score-Matched Analysis.
Kim S, Yun H, Chang H, Kim S, Jeon S, Lee S
Front Oncol. 2022; 12:872130.
PMID: 35558513
PMC: 9086550.
DOI: 10.3389/fonc.2022.872130.
Clinical Implications of Age in Differentiated Thyroid Cancer: Comparison of Clinical Outcomes between Children and Young Adults.
Kim K, Kang S, Lee J, Jeong J, Nam K, Chung W
Int J Endocrinol. 2022; 2022:7804612.
PMID: 35237318
PMC: 8885294.
DOI: 10.1155/2022/7804612.
Puberty and sex in pediatric thyroid cancer: could expression of estrogen and progesterone receptors affect prognosis?.
da Silva Breder J, Alves P, Araujo M, Pires B, Valverde P, Bulzico D
Eur Thyroid J. 2022; 11(2).
PMID: 35113037
PMC: 8963171.
DOI: 10.1530/ETJ-21-0090.
Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span.
Lebbink C, van den Broek M, Kwast A, Derikx J, Dierselhuis M, Kruijff S
Cancers (Basel). 2021; 13(20).
PMID: 34680253
PMC: 8534285.
DOI: 10.3390/cancers13205104.
Papillary thyroid carcinoma in a 5-year old child, mimicking lymphoma in presentation.
Aladily T, Khader M, Bustami N, Samara O
Avicenna J Med. 2021; 11(2):103-106.
PMID: 33996648
PMC: 8101645.
DOI: 10.4103/ajm.ajm_288_20.
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients.
Perreault S, Chami R, Deyell R, El Demellawy D, Ellezam B, Jabado N
Curr Oncol. 2021; 28(1):346-366.
PMID: 33435412
PMC: 7903261.
DOI: 10.3390/curroncol28010038.
Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: An Overview Comparing Pediatric and Adult Populations.
Rangel-Pozzo A, Sisdelli L, Cordioli M, Vaisman F, Caria P, Mai S
Cancers (Basel). 2020; 12(11).
PMID: 33120984
PMC: 7693829.
DOI: 10.3390/cancers12113146.
Papillary Thyroid Carcinoma in Children: Clinicopathological Profile and Outcomes of Management.
Thomas J, Kurian J, Cherian A, Hephzibah J, Paul M, Abraham D
World J Surg. 2020; 45(2):496-506.
PMID: 33078217
DOI: 10.1007/s00268-020-05817-3.
Long-term outcome of differentiated thyroid cancer in children and young adults: risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence.
Karapanou O, Tzanela M, Rondogianni P, Dacou-Voutetakis C, Chiotis D, Vlassopoulou B
Endocrine. 2020; 70(3):566-574.
PMID: 32533509
DOI: 10.1007/s12020-020-02378-2.
Clinical Assessment of Pediatric Patients with Differentiated Thyroid Carcinoma: A 30-Year Experience at a Single Institution.
Kim K, Lee C, Kang S, Lee J, Jeong J, Nam K
World J Surg. 2020; 44(10):3383-3392.
PMID: 32440955
PMC: 7458901.
DOI: 10.1007/s00268-020-05598-9.
Differentiated thyroid carcinoma in children: Clinical characteristics and long-term follow-up.
Tamam M, Uyanik E, Edis N, Mulazimoglu M, Ozpacaci T
World J Nucl Med. 2020; 19(1):28-35.
PMID: 32190019
PMC: 7067138.
DOI: 10.4103/wjnm.WJNM_15_19.
DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131).
Prpic M, Franceschi M, Jukic T, Kust D, Dabelic N, Varjacic T
Acta Clin Croat. 2019; 58(1):119-127.
PMID: 31363334
PMC: 6629190.
DOI: 10.20471/acc.2019.58.01.16.